Symbol:
Lasp1
Name:
LIM and SH3 protein 1
RGD ID:
68408
Description:
Enables monoatomic ion transmembrane transporter activity. Involved in monoatomic ion transport. Located in cortical actin cytoskeleton. Is active in postsynapse. Orthologous to human LASP1 (LIM and SH3 protein 1); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,4,6-trinitrotoluene; 2,4-dibromophenyl 2,4,5-tribromophenyl ether.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
LASP-1; LIM and SH3 domain protein 1
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
LASP1 (LIM and SH3 protein 1)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Lasp1 (LIM and SH3 protein 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Lasp1 (LIM and SH3 protein 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
LASP1 (LIM and SH3 protein 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
LASP1 (LIM and SH3 protein 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Lasp1 (LIM and SH3 protein 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
LASP1 (LIM and SH3 protein 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
LASP1 (LIM and SH3 protein 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Lasp1 (LIM and SH3 protein 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
LASP1 (LIM and SH3 protein 1)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Lasp1 (LIM and SH3 protein 1)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
lasp1 (LIM and SH3 protein 1)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
F42H10.3
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Drosophila melanogaster (fruit fly):
Lasp
Alliance
DIOPT (Ensembl Compara|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
lasp1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 83,290,820 - 83,331,989 (+) NCBI GRCr8 mRatBN7.2 10 82,795,177 - 82,835,659 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 82,795,137 - 82,943,292 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 87,743,471 - 87,783,948 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 87,241,560 - 87,282,036 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 82,634,149 - 82,674,629 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 85,744,662 - 85,785,130 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 85,744,568 - 85,785,133 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 85,533,431 - 85,573,899 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 86,552,612 - 86,593,328 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 86,567,067 - 86,605,176 (+) NCBI Celera 10 81,549,996 - 81,590,495 (+) NCBI Celera Cytogenetic Map 10 q31 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Lasp1 Rat 1,2-dichloroethane increases expression ISO Lasp1 (Mus musculus) 6480464 ethylene dichloride results in increased expression of LASP1 mRNA CTD PMID:28960355 Lasp1 Rat 1,2-dimethylhydrazine affects expression ISO Lasp1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine affects the expression of LASP1 mRNA CTD PMID:22206623 Lasp1 Rat 1,2-dimethylhydrazine multiple interactions ISO Lasp1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LASP1 mRNA CTD PMID:22206623 Lasp1 Rat 17alpha-ethynylestradiol multiple interactions ISO Lasp1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LASP1 mRNA CTD PMID:17942748 Lasp1 Rat 17beta-estradiol affects expression ISO LASP1 (Homo sapiens) 6480464 Estradiol affects the expression of LASP1 mRNA CTD PMID:22574217 Lasp1 Rat 17beta-estradiol increases expression ISO Lasp1 (Mus musculus) 6480464 Estradiol results in increased expression of LASP1 mRNA CTD PMID:39298647 Lasp1 Rat 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO LASP1 (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 Lasp1 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Lasp1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of LASP1 mRNA and [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LASP1 mRNA CTD PMID:16214954 and PMID:17942748 Lasp1 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of LASP1 mRNA CTD PMID:15644576 more ... Lasp1 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Lasp1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of LASP1 mRNA CTD PMID:18796159 and PMID:26290441 Lasp1 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Lasp1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of LASP1 mRNA CTD PMID:21570461 Lasp1 Rat 2,4,6-tribromophenol decreases expression ISO LASP1 (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 Lasp1 Rat 2,4,6-trinitrotoluene affects expression EXP 6480464 Trinitrotoluene affects the expression of LASP1 mRNA CTD PMID:21346803 Lasp1 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:19954255 Lasp1 Rat 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of LASP1 mRNA CTD PMID:21346803 Lasp1 Rat 2,6-dimethoxyphenol multiple interactions ISO LASP1 (Homo sapiens) 6480464 [Sodium Chloride co-treated with pyrogallol 1 and 3-dimethyl ether] results in decreased expression of LASP1 protein CTD PMID:38598786 Lasp1 Rat 2-methylcholine affects expression ISO LASP1 (Homo sapiens) 6480464 beta-methylcholine affects the expression of LASP1 mRNA CTD PMID:21179406 Lasp1 Rat 3,3',5,5'-tetrabromobisphenol A decreases expression ISO LASP1 (Homo sapiens) 6480464 tetrabromobisphenol A results in decreased expression of LASP1 protein CTD PMID:31675489 Lasp1 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO LASP1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LASP1 mRNA CTD PMID:28628672 Lasp1 Rat 4,4'-sulfonyldiphenol affects expression ISO Lasp1 (Mus musculus) 6480464 bisphenol S affects the expression of LASP1 mRNA CTD PMID:39298647 Lasp1 Rat 4-hydroxyphenyl retinamide decreases expression ISO Lasp1 (Mus musculus) 6480464 Fenretinide results in decreased expression of LASP1 mRNA CTD PMID:28973697 Lasp1 Rat 5-fluorouracil affects response to substance ISO LASP1 (Homo sapiens) 6480464 LASP1 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 Lasp1 Rat afimoxifene increases expression ISO LASP1 (Homo sapiens) 6480464 afimoxifene results in increased expression of LASP1 mRNA CTD PMID:16849584 Lasp1 Rat aflatoxin B1 increases expression ISO Lasp1 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of LASP1 mRNA CTD PMID:19770486 Lasp1 Rat Aflatoxin B2 alpha increases methylation ISO LASP1 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of LASP1 intron CTD PMID:30157460 Lasp1 Rat all-trans-retinoic acid increases expression ISO LASP1 (Homo sapiens) 6480464 Tretinoin results in increased expression of LASP1 mRNA CTD PMID:15498508 more ... Lasp1 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of LASP1 mRNA CTD PMID:16483693 Lasp1 Rat aristolochic acid A increases expression ISO LASP1 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of LASP1 mRNA CTD PMID:33212167 Lasp1 Rat Aroclor 1254 decreases expression ISO Lasp1 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of LASP1 mRNA CTD PMID:23650126 Lasp1 Rat arsenous acid multiple interactions ISO LASP1 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to LASP1 protein] CTD PMID:26598702 Lasp1 Rat benzo[a]pyrene decreases expression ISO Lasp1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of LASP1 mRNA CTD PMID:19770486 Lasp1 Rat benzo[a]pyrene affects methylation ISO LASP1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of LASP1 intron CTD PMID:30157460 Lasp1 Rat benzo[a]pyrene multiple interactions ISO Lasp1 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LASP1 mRNA CTD PMID:27858113 Lasp1 Rat benzo[a]pyrene multiple interactions ISO LASP1 (Homo sapiens) 6480464 [Soot co-treated with Benzo(a)pyrene] results in increased expression of LASP1 protein CTD PMID:24464499 Lasp1 Rat benzo[b]fluoranthene multiple interactions ISO Lasp1 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LASP1 mRNA CTD PMID:27858113 Lasp1 Rat beta-lapachone decreases expression ISO LASP1 (Homo sapiens) 6480464 beta-lapachone results in decreased expression of LASP1 mRNA CTD PMID:38218311 Lasp1 Rat bis(2-ethylhexyl) phthalate increases expression ISO LASP1 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of LASP1 mRNA CTD PMID:31163220 Lasp1 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of LASP1 mRNA CTD PMID:25181051 Lasp1 Rat bisphenol A multiple interactions ISO Lasp1 (Mus musculus) 6480464 [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of LASP1 protein CTD PMID:35999755 Lasp1 Rat bisphenol A increases expression ISO Lasp1 (Mus musculus) 6480464 bisphenol A results in increased expression of LASP1 mRNA CTD PMID:32156529 Lasp1 Rat bisphenol A decreases expression ISO Lasp1 (Mus musculus) 6480464 bisphenol A results in decreased expression of LASP1 protein CTD PMID:35999755 Lasp1 Rat bisphenol A multiple interactions ISO LASP1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of LASP1 gene CTD PMID:31601247 Lasp1 Rat bisphenol A decreases expression ISO LASP1 (Homo sapiens) 6480464 bisphenol A results in decreased expression of LASP1 protein CTD PMID:37664457 Lasp1 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LASP1 mRNA CTD PMID:30816183 and PMID:34947998 Lasp1 Rat bisphenol AF increases expression ISO LASP1 (Homo sapiens) 6480464 bisphenol AF results in increased expression of LASP1 protein CTD PMID:34186270 Lasp1 Rat Bisphenol B increases expression ISO LASP1 (Homo sapiens) 6480464 bisphenol B results in increased expression of LASP1 protein CTD PMID:34186270 Lasp1 Rat bisphenol F multiple interactions ISO LASP1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LASP1 mRNA CTD PMID:28628672 Lasp1 Rat bisphenol F increases expression ISO LASP1 (Homo sapiens) 6480464 bisphenol F results in increased expression of LASP1 protein CTD PMID:34186270 Lasp1 Rat bleomycin A2 increases expression EXP 6480464 Bleomycin results in increased expression of LASP1 protein CTD PMID:25933445 Lasp1 Rat Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of LASP1 protein CTD PMID:28903499 Lasp1 Rat cadmium atom increases expression ISO LASP1 (Homo sapiens) 6480464 Cadmium results in increased expression of LASP1 mRNA CTD PMID:23369406 and PMID:24376830 Lasp1 Rat caffeine decreases phosphorylation ISO LASP1 (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of LASP1 protein CTD PMID:35688186 Lasp1 Rat calcium dichloride increases expression ISO LASP1 (Homo sapiens) 6480464 Calcium Chloride results in increased expression of LASP1 protein CTD PMID:25824407 Lasp1 Rat calycosin increases expression ISO LASP1 (Homo sapiens) 6480464 7 and 3'-dihydroxy-4'-methoxyisoflavone results in increased expression of LASP1 protein CTD PMID:24455688 Lasp1 Rat carbon nanotube multiple interactions ISO LASP1 (Homo sapiens) 6480464 [Nanotubes and Carbon co-treated with calfactant] results in decreased expression of LASP1 protein CTD PMID:23026733 Lasp1 Rat carbon nanotube decreases expression ISO Lasp1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 Lasp1 Rat chlordecone decreases expression ISO Lasp1 (Mus musculus) 6480464 Chlordecone results in decreased expression of LASP1 mRNA CTD PMID:33711761 Lasp1 Rat chloropicrin affects expression ISO LASP1 (Homo sapiens) 6480464 chloropicrin affects the expression of LASP1 mRNA CTD PMID:26352163 Lasp1 Rat chlorpyrifos increases expression ISO Lasp1 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of LASP1 mRNA CTD PMID:37019170 Lasp1 Rat chrysene multiple interactions ISO Lasp1 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LASP1 mRNA CTD PMID:27858113 Lasp1 Rat copper(II) sulfate increases expression ISO LASP1 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of LASP1 mRNA CTD PMID:19549813 Lasp1 Rat coumarin affects phosphorylation ISO LASP1 (Homo sapiens) 6480464 coumarin affects the phosphorylation of LASP1 protein CTD PMID:35688186 Lasp1 Rat cumene multiple interactions ISO Lasp1 (Mus musculus) 6480464 [cumene co-treated with KRAS gene mutant form] results in decreased expression of LASP1 mRNA CTD PMID:18648096 Lasp1 Rat cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of LASP1 mRNA CTD PMID:27281708 Lasp1 Rat decabromodiphenyl ether decreases expression ISO LASP1 (Homo sapiens) 6480464 decabromobiphenyl ether results in decreased expression of LASP1 protein CTD PMID:31675489 Lasp1 Rat dexamethasone multiple interactions ISO LASP1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LASP1 mRNA CTD PMID:28628672 Lasp1 Rat dextran sulfate multiple interactions ISO Lasp1 (Mus musculus) 6480464 [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of LASP1 protein CTD PMID:35999755 Lasp1 Rat dextran sulfate decreases expression ISO Lasp1 (Mus musculus) 6480464 Dextran Sulfate results in decreased expression of LASP1 protein CTD PMID:35999755 Lasp1 Rat diarsenic trioxide multiple interactions ISO LASP1 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to LASP1 protein] CTD PMID:26598702 Lasp1 Rat dibutyl phthalate increases expression ISO Lasp1 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of LASP1 mRNA CTD PMID:21266533 Lasp1 Rat dioxygen increases expression ISO Lasp1 (Mus musculus) 6480464 Oxygen deficiency results in increased expression of LASP1 protein CTD PMID:25937538 Lasp1 Rat doxorubicin affects expression ISO LASP1 (Homo sapiens) 6480464 Doxorubicin affects the expression of LASP1 protein CTD PMID:29385562 Lasp1 Rat doxorubicin decreases expression ISO LASP1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of LASP1 mRNA CTD PMID:29803840 Lasp1 Rat epoxiconazole increases expression ISO Lasp1 (Mus musculus) 6480464 epoxiconazole results in increased expression of LASP1 mRNA CTD PMID:35436446 Lasp1 Rat ethanol affects splicing ISO Lasp1 (Mus musculus) 6480464 Ethanol affects the splicing of LASP1 mRNA CTD PMID:30319688 Lasp1 Rat ethanol affects expression ISO Lasp1 (Mus musculus) 6480464 Ethanol affects the expression of LASP1 mRNA CTD PMID:30319688 Lasp1 Rat fenthion decreases expression ISO Lasp1 (Mus musculus) 6480464 Fenthion results in decreased expression of LASP1 mRNA CTD PMID:34813904 Lasp1 Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of LASP1 mRNA CTD PMID:24793618 Lasp1 Rat folic acid multiple interactions ISO Lasp1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LASP1 mRNA CTD PMID:22206623 Lasp1 Rat fulvestrant increases methylation ISO LASP1 (Homo sapiens) 6480464 Fulvestrant results in increased methylation of LASP1 gene CTD PMID:31601247 Lasp1 Rat fulvestrant multiple interactions ISO LASP1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of LASP1 gene CTD PMID:31601247 Lasp1 Rat fumonisin B1 increases expression ISO Lasp1 (Mus musculus) 6480464 fumonisin B1 results in increased expression of LASP1 mRNA CTD PMID:16221962 Lasp1 Rat furan increases methylation EXP 6480464 furan results in increased methylation of LASP1 gene CTD PMID:22079235 Lasp1 Rat furfural multiple interactions ISO LASP1 (Homo sapiens) 6480464 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of LASP1 protein CTD PMID:38598786 Lasp1 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of LASP1 mRNA CTD PMID:22061828 Lasp1 Rat hydralazine multiple interactions ISO LASP1 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of LASP1 mRNA CTD PMID:17183730 Lasp1 Rat hydrogen peroxide decreases secretion ISO Lasp1 (Mus musculus) 6480464 Hydrogen Peroxide results in decreased secretion of LASP1 mRNA CTD PMID:21179422 Lasp1 Rat hydroquinone affects expression ISO LASP1 (Homo sapiens) 6480464 hydroquinone affects the expression of LASP1 protein CTD PMID:20021034 Lasp1 Rat indometacin multiple interactions ISO LASP1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LASP1 mRNA CTD PMID:28628672 Lasp1 Rat inulin multiple interactions ISO Lasp1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LASP1 mRNA CTD PMID:36331819 Lasp1 Rat ivermectin decreases expression ISO LASP1 (Homo sapiens) 6480464 Ivermectin results in decreased expression of LASP1 protein CTD PMID:32959892 Lasp1 Rat lipopolysaccharide multiple interactions ISO LASP1 (Homo sapiens) 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of LASP1 mRNA CTD PMID:35877022 Lasp1 Rat lovastatin decreases expression ISO Lasp1 (Mus musculus) 6480464 Lovastatin results in decreased expression of LASP1 mRNA CTD PMID:20493250 Lasp1 Rat methidathion decreases expression ISO Lasp1 (Mus musculus) 6480464 methidathion results in decreased expression of LASP1 mRNA CTD PMID:34813904 Lasp1 Rat Methylazoxymethanol acetate increases expression EXP 6480464 Methylazoxymethanol Acetate results in increased expression of LASP1 mRNA CTD PMID:28349193 Lasp1 Rat methylphenidate increases expression ISO Lasp1 (Mus musculus) 6480464 Methylphenidate results in increased expression of LASP1 mRNA CTD PMID:22470460 Lasp1 Rat miconazole increases expression ISO Lasp1 (Mus musculus) 6480464 Miconazole results in increased expression of LASP1 mRNA CTD PMID:27462272 Lasp1 Rat microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of LASP1 protein CTD PMID:22430071 Lasp1 Rat naphthalene decreases expression ISO Lasp1 (Mus musculus) 6480464 naphthalene results in decreased expression of LASP1 protein CTD PMID:19438287 Lasp1 Rat O-methyleugenol increases expression ISO LASP1 (Homo sapiens) 6480464 methyleugenol results in increased expression of LASP1 mRNA CTD PMID:32234424 Lasp1 Rat paracetamol decreases expression ISO LASP1 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of LASP1 mRNA CTD PMID:21420995 Lasp1 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of LASP1 mRNA CTD PMID:32479839 and PMID:33387578 Lasp1 Rat paracetamol increases expression ISO LASP1 (Homo sapiens) 6480464 Acetaminophen results in increased expression of LASP1 mRNA CTD PMID:26690555 Lasp1 Rat paraquat increases expression ISO LASP1 (Homo sapiens) 6480464 Paraquat results in increased expression of LASP1 protein CTD PMID:34064677 Lasp1 Rat parathion decreases expression ISO Lasp1 (Mus musculus) 6480464 Parathion results in decreased expression of LASP1 mRNA CTD PMID:34813904 Lasp1 Rat pentachlorophenol affects expression ISO Lasp1 (Mus musculus) 6480464 Pentachlorophenol affects the expression of LASP1 mRNA CTD PMID:23892564 Lasp1 Rat perfluorohexanesulfonic acid decreases expression ISO Lasp1 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of LASP1 mRNA CTD PMID:37995155 Lasp1 Rat perfluorononanoic acid decreases expression ISO LASP1 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of LASP1 mRNA CTD PMID:38568856 Lasp1 Rat perfluorooctane-1-sulfonic acid affects expression ISO Lasp1 (Mus musculus) 6480464 perfluorooctane sulfonic acid affects the expression of LASP1 mRNA CTD PMID:19429403 Lasp1 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Lasp1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LASP1 mRNA CTD PMID:36331819 Lasp1 Rat perfluorooctane-1-sulfonic acid increases expression ISO LASP1 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of LASP1 protein CTD PMID:24301089 Lasp1 Rat perfluorooctanoic acid affects expression ISO Lasp1 (Mus musculus) 6480464 perfluorooctanoic acid affects the expression of LASP1 mRNA CTD PMID:19429403 Lasp1 Rat perfluorooctanoic acid decreases expression ISO LASP1 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of LASP1 protein CTD PMID:26879310 Lasp1 Rat pifithrin-alpha hydrobromide increases expression ISO LASP1 (Homo sapiens) 6480464 pifithrin results in increased expression of LASP1 mRNA CTD PMID:28232485 Lasp1 Rat pirinixic acid decreases expression ISO Lasp1 (Mus musculus) 6480464 pirinixic acid results in decreased expression of LASP1 mRNA CTD PMID:18445702 Lasp1 Rat pregnenolone 16alpha-carbonitrile decreases expression ISO Lasp1 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of LASP1 mRNA CTD PMID:28903501 Lasp1 Rat propiconazole increases expression ISO Lasp1 (Mus musculus) 6480464 propiconazole results in increased expression of LASP1 mRNA CTD PMID:21278054 Lasp1 Rat sarin decreases expression EXP 6480464 Sarin results in decreased expression of LASP1 protein CTD PMID:28973502 Lasp1 Rat SB 431542 multiple interactions ISO LASP1 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of LASP1 protein CTD PMID:37664457 Lasp1 Rat selenomethionine affects expression ISO LASP1 (Homo sapiens) 6480464 Selenomethionine affects the expression of LASP1 mRNA CTD PMID:17222674 Lasp1 Rat sodium arsenite increases expression ISO LASP1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of LASP1 mRNA CTD PMID:38568856 Lasp1 Rat sodium chloride multiple interactions ISO LASP1 (Homo sapiens) 6480464 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of LASP1 protein more ... CTD PMID:38598786 Lasp1 Rat sunitinib increases expression ISO LASP1 (Homo sapiens) 6480464 Sunitinib results in increased expression of LASP1 mRNA CTD PMID:31533062 Lasp1 Rat tamibarotene increases expression ISO LASP1 (Homo sapiens) 6480464 tamibarotene results in increased expression of LASP1 mRNA CTD PMID:15498508 Lasp1 Rat testosterone increases expression ISO Lasp1 (Mus musculus) 6480464 Testosterone results in increased expression of LASP1 mRNA CTD PMID:21669218 Lasp1 Rat tetrachloromethane affects expression ISO Lasp1 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of LASP1 mRNA CTD PMID:31919559 Lasp1 Rat tetraphene multiple interactions ISO Lasp1 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LASP1 mRNA CTD PMID:27858113 Lasp1 Rat thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of LASP1 protein CTD PMID:35544339 Lasp1 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of LASP1 mRNA CTD PMID:34492290 Lasp1 Rat titanium dioxide increases expression ISO Lasp1 (Mus musculus) 6480464 titanium dioxide results in increased expression of LASP1 mRNA CTD PMID:23557971 Lasp1 Rat titanium dioxide decreases methylation ISO Lasp1 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of LASP1 gene CTD PMID:35295148 Lasp1 Rat titanium dioxide increases methylation ISO Lasp1 (Mus musculus) 6480464 titanium dioxide results in increased methylation of LASP1 promoter CTD PMID:35295148 Lasp1 Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of LASP1 mRNA CTD PMID:33387578 Lasp1 Rat triphenyl phosphate affects expression ISO LASP1 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of LASP1 mRNA CTD PMID:37042841 Lasp1 Rat triptonide increases expression ISO Lasp1 (Mus musculus) 6480464 triptonide results in increased expression of LASP1 mRNA CTD PMID:33045310 Lasp1 Rat trovafloxacin increases expression ISO Lasp1 (Mus musculus) 6480464 trovafloxacin results in increased expression of LASP1 mRNA CTD PMID:35537566 Lasp1 Rat valproic acid multiple interactions ISO LASP1 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of LASP1 mRNA CTD PMID:17183730 Lasp1 Rat valproic acid decreases expression ISO LASP1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of LASP1 mRNA CTD PMID:29154799 and PMID:37505509 Lasp1 Rat valproic acid affects expression ISO LASP1 (Homo sapiens) 6480464 Valproic Acid affects the expression of LASP1 mRNA CTD PMID:25979313 Lasp1 Rat vorinostat decreases expression ISO LASP1 (Homo sapiens) 6480464 vorinostat results in decreased expression of LASP1 protein CTD PMID:20543569 Lasp1 Rat warfarin decreases expression ISO Lasp1 (Mus musculus) 6480464 Warfarin results in decreased expression of LASP1 mRNA CTD PMID:20493250
1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4,6-tribromophenol (ISO) 2,4,6-trinitrotoluene (EXP) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (EXP) 2,4-dinitrotoluene (EXP) 2,6-dimethoxyphenol (ISO) 2-methylcholine (ISO) 3,3',5,5'-tetrabromobisphenol A (ISO) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-sulfonyldiphenol (ISO) 4-hydroxyphenyl retinamide (ISO) 5-fluorouracil (ISO) afimoxifene (ISO) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) all-trans-retinoic acid (ISO) ammonium chloride (EXP) aristolochic acid A (ISO) Aroclor 1254 (ISO) arsenous acid (ISO) benzo[a]pyrene (ISO) benzo[b]fluoranthene (ISO) beta-lapachone (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol AF (ISO) Bisphenol B (ISO) bisphenol F (ISO) bleomycin A2 (EXP) Brodifacoum (EXP) cadmium atom (ISO) caffeine (ISO) calcium dichloride (ISO) calycosin (ISO) carbon nanotube (ISO) chlordecone (ISO) chloropicrin (ISO) chlorpyrifos (ISO) chrysene (ISO) copper(II) sulfate (ISO) coumarin (ISO) cumene (ISO) cyclophosphamide (EXP) decabromodiphenyl ether (ISO) dexamethasone (ISO) dextran sulfate (ISO) diarsenic trioxide (ISO) dibutyl phthalate (ISO) dioxygen (ISO) doxorubicin (ISO) epoxiconazole (ISO) ethanol (ISO) fenthion (ISO) flutamide (EXP) folic acid (ISO) fulvestrant (ISO) fumonisin B1 (ISO) furan (EXP) furfural (ISO) gentamycin (EXP) hydralazine (ISO) hydrogen peroxide (ISO) hydroquinone (ISO) indometacin (ISO) inulin (ISO) ivermectin (ISO) lipopolysaccharide (ISO) lovastatin (ISO) methidathion (ISO) Methylazoxymethanol acetate (EXP) methylphenidate (ISO) miconazole (ISO) microcystin-LR (EXP) naphthalene (ISO) O-methyleugenol (ISO) paracetamol (EXP,ISO) paraquat (ISO) parathion (ISO) pentachlorophenol (ISO) perfluorohexanesulfonic acid (ISO) perfluorononanoic acid (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (ISO) pifithrin-alpha hydrobromide (ISO) pirinixic acid (ISO) pregnenolone 16alpha-carbonitrile (ISO) propiconazole (ISO) sarin (EXP) SB 431542 (ISO) selenomethionine (ISO) sodium arsenite (ISO) sodium chloride (ISO) sunitinib (ISO) tamibarotene (ISO) testosterone (ISO) tetrachloromethane (ISO) tetraphene (ISO) thapsigargin (EXP) thioacetamide (EXP) titanium dioxide (ISO) trichloroethene (EXP) triphenyl phosphate (ISO) triptonide (ISO) trovafloxacin (ISO) valproic acid (ISO) vorinostat (ISO) warfarin (ISO)
1.
The LIM and SH3 domain-containing protein, lasp-1, may link the cAMP signaling pathway with dynamic membrane restructuring activities in ion transporting epithelia.
Chew CS, etal., J Cell Sci. 2000 Jun;113 ( Pt 11):2035-45.
2.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
3.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
4.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
5.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
6.
Actin-binding proteins in a postsynaptic preparation: Lasp-1 is a component of central nervous system synapses and dendritic spines.
Phillips GR, etal., J Neurosci Res. 2004 Oct 1;78(1):38-48. doi: 10.1002/jnr.20224.
7.
GOA pipeline
RGD automated data pipeline
8.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
9.
Tentative Sequence Identification Numbers
Tentative Sequence Data IDs. TIGR Gene Index, Rat Data
Lasp1 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 83,290,820 - 83,331,989 (+) NCBI GRCr8 mRatBN7.2 10 82,795,177 - 82,835,659 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 82,795,137 - 82,943,292 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 87,743,471 - 87,783,948 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 87,241,560 - 87,282,036 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 82,634,149 - 82,674,629 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 85,744,662 - 85,785,130 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 85,744,568 - 85,785,133 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 85,533,431 - 85,573,899 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 86,552,612 - 86,593,328 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 86,567,067 - 86,605,176 (+) NCBI Celera 10 81,549,996 - 81,590,495 (+) NCBI Celera Cytogenetic Map 10 q31 NCBI
LASP1 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 17 38,870,058 - 38,921,770 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 17 38,869,859 - 38,921,770 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 17 37,026,311 - 37,078,023 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 17 34,279,894 - 34,331,541 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 17 34,279,893 - 34,331,541 NCBI Celera 17 33,687,074 - 33,739,007 (+) NCBI Celera Cytogenetic Map 17 q12 NCBI HuRef 17 32,821,270 - 32,873,230 (+) NCBI HuRef CHM1_1 17 37,261,377 - 37,313,322 (+) NCBI CHM1_1 T2T-CHM13v2.0 17 39,733,108 - 39,784,846 (+) NCBI T2T-CHM13v2.0
Lasp1 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 11 97,689,748 - 97,729,591 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 11 97,689,826 - 97,729,590 (+) Ensembl GRCm39 Ensembl GRCm38 11 97,799,005 - 97,838,765 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 11 97,799,000 - 97,838,764 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 11 97,660,986 - 97,700,078 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 11 97,615,762 - 97,654,854 (+) NCBI MGSCv36 mm8 Celera 11 107,449,132 - 107,487,995 (+) NCBI Celera Cytogenetic Map 11 D NCBI cM Map 11 61.1 NCBI
Lasp1 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955451 13,910,889 - 13,932,506 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955451 13,910,891 - 13,932,506 (+) NCBI ChiLan1.0 ChiLan1.0
LASP1 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 19 26,026,693 - 26,078,986 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 17 27,910,292 - 27,962,126 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 17 18,350,002 - 18,401,693 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 17 18,623,071 - 18,674,731 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 17 18,623,071 - 18,674,731 (-) Ensembl panpan1.1 panPan2
LASP1 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 9 23,345,226 - 23,397,058 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 9 23,347,881 - 23,396,945 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 9 22,816,905 - 22,868,891 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 9 24,139,876 - 24,191,899 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 9 24,139,879 - 24,180,865 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 9 22,911,898 - 22,963,837 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 9 23,172,943 - 23,224,901 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 9 23,297,911 - 23,350,411 (-) NCBI UU_Cfam_GSD_1.0
Lasp1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405602 22,779,042 - 22,807,935 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936490 14,263,973 - 14,298,951 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936490 14,267,185 - 14,296,114 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
LASP1 (Sus scrofa - pig)
LASP1 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 16 67,268,442 - 67,320,473 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 16 67,267,940 - 67,320,373 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666077 38,264,217 - 38,316,231 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Lasp1 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 561 Count of miRNA genes: 245 Interacting mature miRNAs: 319 Transcripts: ENSRNOT00000005522 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1549846 Scl47 Serum cholesterol level QTL 47 3.6 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 10 50574707 95574707 Rat 1298069 Bp168 Blood pressure QTL 168 5.5 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 10 26521957 98003205 Rat 631552 Vetf2 Vascular elastic tissue fragility QTL 2 4.5 0.0002 aorta elastic tissue integrity trait (VT:0010556) artery internal elastic lamina non-tumorous lesion count (CMO:0001913) 10 41142633 86142633 Rat 61449 Ciaa2 CIA Autoantibody QTL 2 7.1 blood autoantibody amount (VT:0003725) calculated serum anti-type 2 collagen antibody titer (CMO:0001279) 10 63221094 107211142 Rat 631555 Bp134 Blood pressure QTL 134 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 80515287 91230079 Rat 61325 Aia5 Adjuvant induced arthritis QTL 5 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 1298078 Stresp5 Stress response QTL 5 2.99 0.00025 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 10 42045676 104670812 Rat 1549831 Bss6 Bone structure and strength QTL 6 4 lumbar vertebra strength trait (VT:0010574) vertebra ultimate force (CMO:0001678) 10 57576521 102576521 Rat 70164 Bw21 Body weight QTL 21 4.36 0.00005 body mass (VT:0001259) body weight (CMO:0000012) 10 53797494 98952626 Rat 4889948 Bss91 Bone structure and strength QTL 91 4 tibia area (VT:1000281) tibia midshaft total cross-sectional area (CMO:0001715) 10 82564856 92369470 Rat 61463 Bp12 Blood pressure QTL 12 6.3 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 41333258 86333258 Rat 2298548 Neuinf7 Neuroinflammation QTL 7 3.4 nervous system integrity trait (VT:0010566) spinal cord RT1-B protein level (CMO:0002132) 10 72224939 107211142 Rat 1579919 Bp281 Blood pressure QTL 281 0.01 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 74372084 94965338 Rat 1302404 Cia27 Collagen induced arthritis QTL 27 2.6 0.0045 joint integrity trait (VT:0010548) experimental arthritis severity measurement (CMO:0001459) 10 76452683 107211142 Rat 1300107 Rf18 Renal function QTL 18 3.41 urine output (VT:0003620) timed urine volume (CMO:0000260) 10 78775516 98279596 Rat 8694173 Bw149 Body weight QTL 149 4.38 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 10 44441699 89441699 Rat 2300218 Hpcl2 Hepatic cholesterol level QTL 2 liver cholesterol amount (VT:0010498) liver cholesterol level (CMO:0001597) 10 45029650 95600334 Rat 2317754 Glom25 Glomerulus QTL 25 3.5 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 10 82685200 107211142 Rat 1554317 Bmd4 Bone mineral density QTL 4 9.4 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 10 19816042 99406971 Rat 70171 Cari1 Carrageenan-induced inflammation QTL 1 4.9 0.0005 hypodermis integrity trait (VT:0010550) inflammatory exudate volume (CMO:0001429) 10 53797385 107211142 Rat 10450495 Bp383 Blood pressure QTL 383 0.002 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 76246085 94965338 Rat 61354 Pia10 Pristane induced arthritis QTL 10 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 2292617 Ept18 Estrogen-induced pituitary tumorigenesis QTL 18 3.9 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 10 73453136 96120911 Rat 2301967 Cm73 Cardiac mass QTL 73 4.55 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 10 14487011 89062041 Rat 2313103 Bss80 Bone structure and strength QTL 80 2 0.0001 tibia strength trait (VT:1000284) tibia midshaft endosteal cross-sectional area (CMO:0001716) 10 62057807 107057807 Rat 2293646 Bss25 Bone structure and strength QTL 25 10.96 0.0001 femur morphology trait (VT:0000559) femur cross-sectional area (CMO:0001661) 10 69738412 107211142 Rat 2303118 Mamtr7 Mammary tumor resistance QTL 7 0.003 mammary gland integrity trait (VT:0010552) mammary tumor growth rate (CMO:0000344) 10 9658275 104670812 Rat 70188 BpQTLcluster1 Blood pressure QTL cluster 1 4.864 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 1 42323132 87323132 Rat 2300172 Bmd57 Bone mineral density QTL 57 9.8 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 10 69738412 107211142 Rat 724516 Uae17 Urinary albumin excretion QTL 17 3.6 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 10 78210622 85220348 Rat 70193 Mcs7 Mammary carcinoma susceptibility QTL 7 2.38 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 10 72224939 107211142 Rat 2313105 Bss79 Bone structure and strength QTL 79 1.8 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 10 62057807 107057807 Rat 9589030 Epfw9 Epididymal fat weight QTL 9 19.24 0.001 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 10 44441699 89441699 Rat 1357344 Bp249 Blood pressure QTL 249 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 66743655 98003205 Rat 2316949 Gluco60 Glucose level QTL 60 3.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 10 14487011 107057807 Rat 70198 BpQTLcluster9 Blood pressure QTL cluster 9 2.94 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 42323132 87323132 Rat 2306970 Anxrr22 Anxiety related response QTL 22 5.95 fear/anxiety-related behavior trait (VT:1000241) number of periods of voluntary immobility (CMO:0001045) 10 61345276 98211570 Rat 1359017 Hrtrt21 Heart rate QTL 21 2.4 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 10 51772940 96772940 Rat 2293663 Bss33 Bone structure and strength QTL 33 9.34 0.0001 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 10 69738412 107211142 Rat 7387312 Bw125 Body weight QTL 125 3 0.0047 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight (CMO:0000356) 10 64890616 107211142 Rat 2312672 Insul15 Insulin level QTL 15 0.01 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 10 57134272 102134272 Rat 6893357 Bw102 Body weight QTL 102 0.5 0.36 body mass (VT:0001259) body weight (CMO:0000012) 10 80515287 101325465 Rat 2317029 Aia19 Adjuvant induced arthritis QTL 19 2.98 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 10 66978955 107211142 Rat 2303589 Bw87 Body weight QTL 87 2 body mass (VT:0001259) body weight (CMO:0000012) 10 81285008 107211142 Rat 724556 Pur2 Proteinuria QTL 2 5.5 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 10 22427500 90627625 Rat 2306793 Ean5 Experimental allergic neuritis QTL 5 4.7 nervous system integrity trait (VT:0010566) IFNG-secreting splenocyte count (CMO:0002122) 10 72552416 93995749 Rat 61387 Bp1 Blood pressure QTL 1 5.1 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 10 51770177 107211142 Rat 2317039 Aia6 Adjuvant induced arthritis QTL 6 4.31 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 10 66978955 107211142 Rat 61396 Bp9 Blood pressure QTL 9 4.8 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 68420376 107211142 Rat 1358915 Stresp7 Stress response QTL 7 3.52 blood norepinephrine amount (VT:0005663) plasma norepinephrine level (CMO:0001010) 10 78899655 87307728 Rat 1331791 Cm31 Cardiac mass QTL 31 3.84606 heart mass (VT:0007028) heart wet weight (CMO:0000069) 10 29299504 107211142 Rat 70364 Bp72 Blood pressure QTL 72 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 51121100 96121100 Rat 10450498 Bp384 Blood pressure QTL 384 0.002 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 67750049 107211142 Rat 4889492 Pancm2 Pancreatic morphology QTL 2 3.2 pancreatic beta cell morphology trait (VT:0005217) ratio of insulin-positive cell area to total area of splenic region of pancreas (CMO:0001814) 10 76748906 107211142 Rat 6893366 Bw106 Body weight QTL 106 0.3 0.47 body mass (VT:0001259) body weight (CMO:0000012) 10 70199100 107211142 Rat 2293698 Bss43 Bone structure and strength QTL 43 5.33 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra cross-sectional area (CMO:0001689) 10 59209888 104209888 Rat 631530 Tls3 T-lymphoma susceptibility QTL 3 0 0.0001 thymus integrity trait (VT:0010555) percentage of study population developing T-cell lymphomas during a period of time (CMO:0001911) 10 51774612 95600334 Rat 1354608 Cm33 Cardiac mass QTL 33 2.8 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 10 54809292 99809292 Rat 1558643 Cm44 Cardiac mass QTL 44 4.8 0.0000368 heart mass (VT:0007028) heart wet weight (CMO:0000069) 10 61345276 99703528 Rat 631535 Cm51 Cardiac mass QTL 51 3 heart mass (VT:0007028) calculated heart weight (CMO:0000073) 10 51786282 91669536 Rat 631267 Cia20 Collagen induced arthritis QTL 20 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 1576308 Schws1 Schwannoma susceptibility QTL 1 0.0041 nervous system integrity trait (VT:0010566) percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) 10 40035094 102359817 Rat 631269 Cia22 Collagen induced arthritis QTL 22 8.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 631268 Cia21 Collagen induced arthritis QTL 21 3.1 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 14487011 104060283 Rat 631270 Cia23 Collagen induced arthritis QTL 23 3.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 7411614 Foco18 Food consumption QTL 18 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 10 44441699 89441699 Rat 2325836 Bp346 Blood pressure QTL 346 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 76246085 84007272 Rat 6893336 Cm75 Cardiac mass QTL 75 0.1 0.87 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 10 61345276 99703528 Rat 12880053 Cm104 Cardiac mass QTL 104 0.009 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 10 73452992 83463334 Rat 631547 Bp87 Blood pressure QTL 87 4.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 47369470 92369470 Rat 61427 Cia16 Collagen induced arthritis QTL 16 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 6357896 96121100 Rat 2292438 Bp311 Blood pressure QTL 311 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 76246085 107211142 Rat 2312662 Slep8 Serum leptin concentration QTL 8 0.05 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 10 57134272 102134272 Rat 12880050 Am10 Aortic mass QTL 10 0.016 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 10 74372084 84007272 Rat 1358188 Ept9 Estrogen-induced pituitary tumorigenesis QTL 9 3.9 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 10 73453136 96120911 Rat 631537 Oia4 Oil induced arthritis QTL 4 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 75631887 87055282 Rat 634354 Rends3 Renal damage susceptibility QTL 3 0.05 kidney blood vessel morphology trait (VT:0000530) organ lesion measurement (CMO:0000677) 10 79813789 85160854 Rat 1642980 Bp300 Blood pressure QTL 300 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 68383129 107211142 Rat 631542 Bp82 Blood pressure QTL 82 6.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 26521957 98952741 Rat 2312668 Scl65 Serum cholesterol level QTL 65 0.001 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 10 57134272 102134272 Rat
RH133294
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 10 83,331,621 - 83,331,823 (+) Marker Load Pipeline mRatBN7.2 10 82,835,291 - 82,835,493 (+) MAPPER mRatBN7.2 Rnor_6.0 10 85,784,763 - 85,784,964 NCBI Rnor6.0 Rnor_5.0 10 85,573,532 - 85,573,733 UniSTS Rnor5.0 RGSC_v3.4 10 86,592,963 - 86,593,164 UniSTS RGSC3.4 Celera 10 81,590,130 - 81,590,331 UniSTS RH 3.4 Map 10 878.09 UniSTS Cytogenetic Map 10 q31 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000005522 ⟹ ENSRNOP00000005522
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 82,795,137 - 82,943,292 (+) Ensembl Rnor_6.0 Ensembl 10 85,744,568 - 85,785,133 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000102880 ⟹ ENSRNOP00000078535
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 82,795,237 - 82,835,564 (+) Ensembl
RefSeq Acc Id:
NM_032613 ⟹ NP_116002
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 83,291,518 - 83,331,987 (+) NCBI mRatBN7.2 10 82,795,177 - 82,835,657 (+) NCBI Rnor_6.0 10 85,744,662 - 85,785,128 (+) NCBI Rnor_5.0 10 85,533,431 - 85,573,899 (+) NCBI RGSC_v3.4 10 86,552,612 - 86,593,328 (+) RGD Celera 10 81,549,996 - 81,590,495 (+) RGD
Sequence:
GCCGCCGCCTCCTCCTACCAGCTCGCCCAAGGAAAAGGGAACGCGCGCGAGCACGGGCGTTCCCGCCCCAGTCTTTCCCCGGAACCATGAACCCTAACTGTGCCCGGTGCGGCAAAATCGTGTACCCC ACGGAGAAGGTGAACTGTCTGGATAAGTTCTGGCATAAAGCATGCTTTCACTGCGAGACCTGCAAGATGACTTTGAACATGAAGAACTACAAGGGTTACGAGAAGAAGCCTTACTGCAATGCACACTA CCCCAAGCAGTCCTTCACCATGGTGGCCGACACTCCGGAGAACCTCCGCCTGAAGCAACAGAGCGAGCTGCAGAGTCAGGTGCGTTACAAGGAGGAGTTTGAGAAGAACAAGGGCAAAGGCTTCAGTG TGGTGGCAGACACGCCTGAACTGCAGAGAATCAAGAAGACCCAGGACCAGATCAGCAATATCAAATACCATGAGGAGTTTGAGAAGAGCCGCATGGGGCCCAGCGGAGGTGAAGGCATAGAGCCAGAG CGCCGAGAAGCCCAGGACAGCAGCAGCTACCGGAGGCCCACGGAGCAGCAACAGCCACAGCCCCACCATATCCCGACCAGTGCCCCAGTTTACCAGCAGCCCCAACAGCAGCAGGTGACCCCGTCCTA TGGTGGGTACAAGGAGCCAGCAGCCCCTGTCTCCATACAGCGCAGTGCCCCAGGTGGCGGCGGGAAACGGTACCGTGCAGTGTATGACTACAGCGCTGCCGATGAGGACGAGGTCTCCTTCCAGGATG GGGACACCATCGTCAATGTGCAGCAGATCGATGATGGCTGGATGTATGGGACCGTAGAGCGCACCGGTGACACGGGGATGCTGCCAGCCAACTATGTTGAGGCCATCTGAGCCCCGTGCTGCCCCACC CTGTCTTCAATGCATTCCATGGCATCACATCTGTCCTGGGGCCTGACCCATCCACCCTTCAGTGTCTCTGTCTCTTAAGATCTTCAACTGCTTCTTTATCCCCGCCCCTCCTCCAGCTTCCTTTGCCA ACCTAAGCCTTGTTCTGCTCCTGTCGTGGGCTCCTTCCTCTGGCAGGTTTCCCTTGGACCAATCAACTGATTGATTTTTCTCTCTGGATGGAACAGGCTGGGCACTCTGAGGAGGGCAGGATTGTTCT GAGGAGGGTGGGATCACAGGGCTGGGCTGAAACGAGAGACCCATTAAGGAGATCGGTTAGACTGGGTGTGGTGGCATACACCTTTAATCCCAGCAGAGGATTCATCCCAGCAAAGGGGGGAAGAGGCA GGCAGATCTGTGACTTTGAAGCCAGTCTGGTCTACATCATGAGTTTCATGAGGGCCAGAGCTATGTAGTGAGACCCTGTCTCGAGGGAGGAGGGACTGGTTAGCTCTTAGCTTCACTTCCCACCTTAG GCCCGTTGGAACCCCTGGCCCAGCTCCTCTGCACCCTTCTGCCTAGAGCTGGGGTGAGCTGCATACTCCTCATCCCGCCAGGTGGGGCTCCACACATTCCCAGGGGGTGGGTGTTAAGGCCTCAGTTA TGTAAAGAGCAATGTGATGGCCTTCCCCTAGTCCATCTCTCTGCCTCCTCAGGGCATCCAGGGGAGGGCAGACTTTCTGCTTCAGGCTGAATCCCTGCCCCTCTGTTCCTTCACACACTGGAGTGTGC CATTCTGCCCACACAAACCTAGGGCGGCCAAAGAGCTCCCCAGAAATCCCAGCTTGGGTCAGATTCTTGCCTTAGTTCTAGGGGCAGCAGCAGAAAGGAGGGAACGGGGTGTTCTCCTGGGCCCGATT GCTTCCCTCCTCCCCCAGCCTCCTGGGACTCATTATCTCCCTGGCTGGGAGCCTGCTGTGAAGGGTAGAGCAAGGGAAGCCTTTGGGACTTGACTGAGCTGTTTCTTCCTGCTCCGCTGGGGAAAGGT CTCTGTGTCTCCTATGGCCTTCCTTCCCTGGAACAAGGCTGGACTAGCCTAGAGCTCTGCAGTGACAGAAAAATGGCAAGAGTTTTCTGGAGCACAGGAGGCCCTCCCACCTCCGCAGTGAGGTGGGA GAAGGCTTCTGCGTTAGATGTGTGCTTTCCTGTCTTTGTGTCTGAGGCTACAGAGGGACCAAGTCACCCACACACTGTGGCACCTCACCTGAGGCTCTTCTGTCCTTGGAGCAAAGGAGGGAGTCCAG GGCTCCAAGGCTGGCGGCACCATCTCTGGGCTGGTGCTAAACTCAAGTTCCTCCTTTGCATCTGGGGCCCGGGACAGTACTCACTCGATTTCATTCATCTCGGGCTTTTCTTGTCACTCCTCCTGGGT CTCCTGACTCATCTTTACCCTGAGTGTGATGTCAGGTCCCTTTACATACTCAGACCCTGCTGCAGGTGACCTTTGAACCTGAAGACCTTGGCCAGGCTAGCAGTGTGGTGTCATGAGGGCTTGCTAGA GTAAACCATCTTCCTGCCTGGTCAATCCTTTTACCTCCGACCCTAGCCTGGGTGAAGGCAAGGAGTGTTCTGGTGGGCAACATGGGGAGAACCTTGTAGGAGCATCTCAGGAGCTACTGGGGAGGTGC CCCACCCACTCCACTTCTCCTTGATCTCAAAGCACAATGCGGTTCTGGGGACCAGGGTTCAGGGGCGCTTGCTCTTGGAGGGCCTGTGTTCAGGAGGTGCTACAAGCCTCCTGGTTCCTCTCAGCTGA GCCTCCCTTCCCAACATGTCAAGTCAGCTGCTCCTTTAGTGCCCTAGAACTGGGGGAGACTTTCCCACACCTGCAGAGGGAAGAGGAACTACCAAAGGTGCTGAGGGCCCCAAGCCTGCTGGAGTCCA TACTTTTCCAGAAGCATCCAACCCTAGAAGAGCACAGAATCCCCAAGCCCATGGTCTCTTCCTTTGTAAAGGTCTTTTCAGCCAATCAAAACCCAGGAAAGAGGGCGCCTTGGCTAGACTGTGAACTT AACTTTTGTGGACCAATCCTGTAGCGCAAGAAGCCCCGTGGTGAGGAGCATGAGTTCTTCCCATGCTGCTTCCTGTCCCCTCCTCATGTCCCTCCAGGGAACATTTCATTTCCTAATAGCTGGACACA AGACAAAAAGAACCACCCCACAGAGCCTGTATTTAAACAGAAACAGAAGTGACCCTGTGAAGTCCACCTCTGTCTAACATTTCATCCGTGTTTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGCGTGTG AAGCCACCACTCATCTTTTATATCGGATTGTCATCTTTCTTTGGTCTGTTTGGTCCCCTCCCTCCTGGCCTTGTGCTTGGGATCAATTCTTTCTGGCCTGTTATGATTTTTGAACATTGACTTGAACC ACAAAGTGAATCTTTATCCTGGTGACTCAAATAAAAGTATAATTTTTACCTGCGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
XM_006247288 ⟹ XP_006247350
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 83,292,097 - 83,331,989 (+) NCBI mRatBN7.2 10 82,795,784 - 82,835,659 (+) NCBI Rnor_6.0 10 85,745,258 - 85,785,130 (+) NCBI Rnor_5.0 10 85,533,431 - 85,573,899 (+) NCBI
Sequence:
CTACCCGCTCGGCTTGGGCTGCTGGTAGCCTGGCTTCCTGGCTTGGAAGCTGCTTCGGGTCTTTGGTCTAGCGAGTGTCAATTGAGTTCTGGCATAAAGCATGCTTTCACTGCGAGACCTGCAAGATG ACTTTGAACATGAAGAACTACAAGGGTTACGAGAAGAAGCCTTACTGCAATGCACACTACCCCAAGCAGTCCTTCACCATGGTGGCCGACACTCCGGAGAACCTCCGCCTGAAGCAACAGAGCGAGCT GCAGAGTCAGGTGCGTTACAAGGAGGAGTTTGAGAAGAACAAGGGCAAAGGCTTCAGTGTGGTGGCAGACACGCCTGAACTGCAGAGAATCAAGAAGACCCAGGACCAGATCAGCAATATCAAATACC ATGAGGAGTTTGAGAAGAGCCGCATGGGGCCCAGCGGAGGTGAAGGCATAGAGCCAGAGCGCCGAGAAGCCCAGGACAGCAGCAGCTACCGGAGGCCCACGGAGCAGCAACAGCCACAGCCCCACCAT ATCCCGACCAGTGCCCCAGTTTACCAGCAGCCCCAACAGCAGCAGGTGACCCCGTCCTATGGTGGGTACAAGGAGCCAGCAGCCCCTGTCTCCATACAGCGCAGTGCCCCAGGTGGCGGCGGGAAACG GTACCGTGCAGTGTATGACTACAGCGCTGCCGATGAGGACGAGGTCTCCTTCCAGGATGGGGACACCATCGTCAATGTGCAGCAGATCGATGATGGCTGGATGTATGGGACCGTAGAGCGCACCGGTG ACACGGGGATGCTGCCAGCCAACTATGTTGAGGCCATCTGAGCCCCGTGCTGCCCCACCCTGTCTTCAATGCATTCCATGGCATCACATCTGTCCTGGGGCCTGACCCATCCACCCTTCAGTGTCTCT GTCTCTTAAGATCTTCAACTGCTTCTTTATCCCCGCCCCTCCTCCAGCTTCCTTTGCCAACCTAAGCCTTGTTCTGCTCCTGTCGTGGGCTCCTTCCTCTGGCAGGTTTCCCTTGGACCAATCAACTG ATTGATTTTTCTCTCTGGATGGAACAGGCTGGGCACTCTGAGGAGGGCAGGATTGTTCTGAGGAGGGTGGGATCACAGGGCTGGGCTGAAACGAGAGACCCATTAAGGAGATCGGTTAGACTGGGTGT GGTGGCATACACCTTTAATCCCAGCAGAGGATTCATCCCAGCAAAGGGGGGAAGAGGCAGGCAGATCTGTGACTTTGAAGCCAGTCTGGTCTACATCATGAGTTTCATGACGGCCAGAGCTATGTAGT GAGACCCTGTCTCGAGGGAGGAGGGACTGGTTAGCTCTTAGCTTCACTTCCCACCTTAGGCCCGTTGGAACCCCTGGCCCAGCTCCTCTGCACCCTTCTGCCTAGAGCTGGGGTGAGCTGCATACTCC TCATCCCACCAGGTGGGGCTCCACACATTCCCAGGGGGTGGGTGTTAAGGCCTCAGTTATGTAAAGAGCAATGTGATGGCCTTCCCCTAGTCCATCTCTCTGCCTCCTCAGGGCATCCAGGGGAGGGC AGACTTTCTGCTTCAGGCTGAATCCCTGCCCCTCTGTTCCTTCACACACTGGAGTGTGCCATTCTGCCCACACAAACCTAGGGCGGCCAAAGAGCTCCCCAGAAATCCCAGCTTGGGTCAGATTCTTG CCTTAGTTCTAGGGGCAGCAGCAGAAAGGAGGGAACGGGGTGTTCTCCTGGGCCCGATTGCTTCCCTCCTCCCCCAGCCTCCTGGGACTCATTATCTCCCTGGCTGGGAGCCTGCTGTGAAGGGTAGA GCAAGGGAAGCCTTTGGGACTTGACTGAGCTGTTTCTTCCTGCTCCGCTGGGGAAAGGTCTCTGTGTCTCCTATGGCCTTCCTTCCCTGGAACAAGGCTGGACTAGCCTAGAGCTCTGCAGTGACAGA AAAATGGCAAGAGTTTTCTGGAGCACAGGAGGCCCTCCCACCTCCGCAGTGAGGTGGGAGAAGGCTTCTGCGTTAGATGTGTGCTTTCCTGTCTTTGTGTCTGAGGCTACAGAGGGACCAAGTCACCC ACACACTGTGGCACCTCACCTGAGGCTCTTCTGTCCTTGGAGCAAAGGAGGGAGTCCAGGGCTCCAAGGCTGGCGGCACCATCTCTGGGCTGGTGCTAAACTCAAGTTCCTCCTTTGCATCTGGGGCC CGGGACAGTACTCACTCGATTTCATTCATCTCGGGCTTTTCTTGTCACTCCTCCTGGGTCTCCTGACTCATCTTTACCCTGAGTGTGATGTCAGGTCCCTTTACATACTCAGACCCTGCTGCAGGTGA CCTTTGAACCTGAAGACCTTGGCCAGGCTAGCAGTGTGGTGTCATGAGGGCTTGCTAGAGTAAACCATCTTCCTGCCTGGTCAATCCTTTTACCTCCGACCCTAGCCTGGGTGAAGGCAAGGAGTGTT CTGGTGGGCAACATGGGGAGAACCTTGTAGGAGCATCTCAGGAGCTACTGGGGAGGTGCCCCACCCACTCCACTTCCCCTTGATCTCAAAGCACAATGCGGTTCTGGGGACCAGGGTTCAGGGGCGCT TGCTCTTGGAGGGCCTGTGTTCAGGAGGTGCTACAAGCCTCCTGGTTCCTCTCAGCTGAGCCTCCCTTCCCAACATGTCAAGTCAGCTGCTCCTTTAGTGCCCTAGAACTGGGGGAGACTTTCCCACA CCTGCAGAGGGAAGAGGAACTACCAAAGGTGCTGAGGGCCCCAAGCCTGCTGGAGTCCATACTTTTCCAGAAGCATCCAACCCTAGAAGAGCACAGAATCCCCAAGCCCATGGTCTCTTCCTTTGTAA AGGTCTTTTCAGCCAATCAAAACCCAGGAAAGAGGGCGCCTTGGCTAGACTGTGAACTTAACTTTTGTGGACCAATCCTGTAGCGCAAGAAGCCCCGTGGTGAGGAGCATGAGTTCTTCCCATGCTGC TTCCTGTCCCCTCCTCATGTCCCTCCAGGGAACATTTCATTTCCTAATAGCTGGACACAAGACAAAAAGAACCACCCCACAGAGCCTGTATTTAAACAGAAACAGAAGTGACCCTGTGAAGTCCACCT CTGTCTAACATTTCATCCGTGTTTTTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGCGTGTGAAGCCACCACTCATCTTTTATATCGGATTGTCATCTTTCTTTGGTCTGTTT GGTCCCCTCCCTCCTGGCCTTGTGCTTGGGATCAATTCTTTCTGGCCTGTTATGATTTTTGAACATTGACTTGAACCACAAAGTGAATCTTTATCCTGGTGACTCAAATAAAAGTATAATTTTTACCT GCGGA
hide sequence
RefSeq Acc Id:
XM_063268798 ⟹ XP_063124868
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 83,290,820 - 83,331,989 (+) NCBI
RefSeq Acc Id:
XM_063268799 ⟹ XP_063124869
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 83,298,972 - 83,331,989 (+) NCBI
RefSeq Acc Id:
NP_116002 ⟸ NM_032613
- UniProtKB:
Q499R9 (UniProtKB/Swiss-Prot), Q99MZ8 (UniProtKB/Swiss-Prot), A6HIN2 (UniProtKB/TrEMBL), A0A8I6G1X8 (UniProtKB/TrEMBL)
- Sequence:
MNPNCARCGKIVYPTEKVNCLDKFWHKACFHCETCKMTLNMKNYKGYEKKPYCNAHYPKQSFTMVADTPENLRLKQQSELQSQVRYKEEFEKNKGKGFSVVADTPELQRIKKTQDQISNIKYHEEFEK SRMGPSGGEGIEPERREAQDSSSYRRPTEQQQPQPHHIPTSAPVYQQPQQQQVTPSYGGYKEPAAPVSIQRSAPGGGGKRYRAVYDYSAADEDEVSFQDGDTIVNVQQIDDGWMYGTVERTGDTGMLP ANYVEAI
hide sequence
RefSeq Acc Id:
XP_006247350 ⟸ XM_006247288
- Peptide Label:
isoform X2
- UniProtKB:
A0A8I6G1X8 (UniProtKB/TrEMBL)
- Sequence:
MTLNMKNYKGYEKKPYCNAHYPKQSFTMVADTPENLRLKQQSELQSQVRYKEEFEKNKGKGFSV VADTPELQRIKKTQDQISNIKYHEEFEKSRMGPSGGEGIEPERREAQDSSSYRRPTEQQQPQPHHIPTSAPVYQQPQQQQVTPSYGGYKEPAAPVSIQRSAPGGGGKRYRAVYDYSAADEDEVSFQDG DTIVNVQQIDDGWMYGTVERTGDTGMLPANYVEAI
hide sequence
Ensembl Acc Id:
ENSRNOP00000005522 ⟸ ENSRNOT00000005522
Ensembl Acc Id:
ENSRNOP00000078535 ⟸ ENSRNOT00000102880
RefSeq Acc Id:
XP_063124868 ⟸ XM_063268798
- Peptide Label:
isoform X1
- UniProtKB:
Q99MZ8 (UniProtKB/Swiss-Prot), Q499R9 (UniProtKB/Swiss-Prot), A6HIN2 (UniProtKB/TrEMBL), A0A8I6G1X8 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063124869 ⟸ XM_063268799
- Peptide Label:
isoform X3
RGD ID: 13697651
Promoter ID: EPDNEW_R8176
Type: initiation region
Name: Lasp1_1
Description: LIM and SH3 protein 1
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 10 85,744,620 - 85,744,680 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2002-06-10
Lasp1
LIM and SH3 protein 1
Name updated
70584
APPROVED